AER - Volume 3 Issue 1 Spring 2014

This issue of Arrhythmia & Electrophysiology Review – Volume 3 Issue 1 – includes a number of contributions aimed at providing comprehensive reviews of relevance to the general cardiologist and the electrophysiologist, from current recommendations for cardiac resynchronisation therapy (Dewhurst and Linker) to the ablation of arrhythmias in adult congenital heart disease (Lobo et al). Fragakis et al discuss the mechanisms and management of atrial fibrillation in endurance athletes, while Hucker et al review device-based approaches for modulation of the autonomic nervous system. Looi et al describe the change of clinical settings for cardiac resynchronisation therapy.


The pace at which Arrhythmia & Electrophysiology Review is maturing is really impressive. We are now preparing our fourth issue and the volume of manuscripts considered, the quality of accepted papers, and the names behind them, are really amazing. It is obvious that the electrophysiology community is convinced about the need for regular reviews and summary articles on our ever-evolving and intellectually demanding discipline. Apart from submitting their excellent papers, our colleagues have also wholeheartedly responded towards supporting the reviewing and editing process of our journal. I am proud to announce that Karl-Heinz Kuck has joined us as Section Editor on Clinical Electrophysiology and Ablation, and Angelo Auricchio as Section Editor on Implantable Devices. Together with Andrew Grace, our Section Editor on Arrhythmia Mechanisms and Basic Science, they comprise a very promising team indeed. I am also very glad to welcome Sonny Jackman, Bill Stevenson, Sunny Po and Frank Marchlinski onto our editorial board. I am sure none of them needs any introduction.

Please continue to support Arrhythmia & Electrophysiology Review with your high-quality contributions. We have already initiated the process of getting the journal into PubMed and Medline, and we can all be assured that our papers will not only be valuable tools for clinicians and scientists; they will also be properly identifiable and contribute to the recognition of our efforts. This will be the epitome of our success.

Demosthenes Katritsis, Editor-in-Chief